Additional funding is needed for global health product development. A number of promising global health vaccine and drug candidates have entered the expensive later-stages of clinical development. At the same time, increasing pressure on public sector and private donors have dampened the outlook for future product development grant funding.
The foundation seeks to improve global health by supporting the development of global health products. We aim to identify new funding sources for late-stage clinical development of global health priorities and to develop a vehicle that will attract private sector capital from high-net worth individuals, foundations and pharmaceutical companies to invest in the development of global health products that have the potential to generate a positive financial return.
Global Health Investment Corporation
Non-profit established to serve as the managing member of the fund
Lion’s Head Global Partners
London and Nairobi – based merchant bank with expertise in global health that will serve as the Investment Manager
Foundation focus: Global health product development
Guaranty: backstop of global health financing facility
Date: December 2012
Co-Investors: GSK, CIFF, Grand Challenges Canada, IFC, KfW, Merck & Co., Inc., Kenilworth NJ USA, the Pfizer Foundation, JP Morgan Social Finance, Storebrand, and several high-net-worth individuals